These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 17049672

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Phase I study of concurrent high-dose three-dimensional conformal radiotherapy with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small-cell lung cancer.
    Sekine I, Sumi M, Ito Y, Horinouchi H, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Kubota K, Tamura T.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):953-9. PubMed ID: 21377282
    [Abstract] [Full Text] [Related]

  • 43. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
    Giorgio CG, Pappalardo A, Russo A, Santini D, Di Rosa C, Di Salvo C, Castorina S, Marletta F, Bellissima G, Palermo N, Scuderi C, Bordonaro R.
    Anticancer Drugs; 2007 Jul 01; 18(6):713-9. PubMed ID: 17762402
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine.
    Viñolas N, Provencio M, Reguart N, Cardenal F, Alberola V, Sánchez-Torres JM, Barón FJ, Cobo M, Maestu I, Moreno I, Mesía C, Izquierdo A, Felip E, López-Brea M, Márquez A, Sánchez-Ronco M, Tarón M, Santarpia MC, Rosell R, Spanish Lung Cancer Group.
    Lung Cancer; 2011 Feb 01; 71(2):191-8. PubMed ID: 20627363
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
    Clark JI, Kancharla K, Qamar R, Fisher S, Hantel A, Panganiban J, Millbrandt L, Albain KS.
    Lung Cancer; 2001 Nov 01; 34(2):271-7. PubMed ID: 11679186
    [Abstract] [Full Text] [Related]

  • 49. Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial.
    Gridelli C, Manegold C, Mali P, Reck M, Portalone L, Castelnau O, Stahel R, Betticher D, Pless M, Pons JT, Aubert D, Burillon JP, Parlier Y, De Marinis F.
    Eur J Cancer; 2004 Nov 01; 40(16):2424-31. PubMed ID: 15519515
    [Abstract] [Full Text] [Related]

  • 50. Continuous infusion cisplatin and 5-fluorouracil with bolus vinorelbine in the treatment of advanced nonsmall cell carcinoma of the lung.
    Beuzeboc P, Livartowski A, Dierick A, Paraiso D, Pouillart P.
    J Infus Chemother; 1995 Nov 01; 5(4):193-4. PubMed ID: 8934725
    [Abstract] [Full Text] [Related]

  • 51. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.
    Alam N, Shepherd FA, Winton T, Graham B, Johnson D, Livingston R, Rigas J, Whitehead M, Ding K, Seymour L.
    Lung Cancer; 2005 Mar 01; 47(3):385-94. PubMed ID: 15713522
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study.
    Carabante-Ocón F, Cobo-Dols M, Benavides-Orgaz M, Gil-Calle S, Alés-Díaz I, Bretón-García JJ, Villar-Chamorro E, Montesa-Pino A, Alcalde-García J, Gutiérrez-Calderón V.
    Clin Lung Cancer; 2005 Sep 01; 7(2):121-6. PubMed ID: 16179099
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Phase I study of amrubicin hydrochloride and cisplatin in patients previously treated for advanced non-small cell lung cancer.
    Ikeda J, Maruyama R, Okamoto T, Shoji F, Wataya H, Ichinose Y.
    Jpn J Clin Oncol; 2006 Jan 01; 36(1):12-6. PubMed ID: 16418184
    [Abstract] [Full Text] [Related]

  • 56. Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I-IIIB): a phase II study.
    Winterhalder R, Deschler-Marini S, Landmann C, Kann R, Passweg J, Herrmann R, Pless M.
    Radiother Oncol; 2004 Dec 01; 73(3):321-4. PubMed ID: 15588877
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. UFT plus vinorelbine in advanced non-small cell lung cancer: a phase I and an elderly patient-directed phase II study.
    Igishi T, Shigeoka Y, Yasuda K, Suyama H, Katayama S, Sugitani A, Matsumoto S, Yamamoto M, Ueda Y, Takeda K, Sumikawa T, Sako T, Kodani M, Hitsuda Y, Shimizu E.
    J Thorac Oncol; 2009 Mar 01; 4(3):376-82. PubMed ID: 19190514
    [Abstract] [Full Text] [Related]

  • 59. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial.
    Burkes RL, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson FG, Jones D, Farooq S, McGlaughlin J, Ginsberg RJ.
    Lung Cancer; 2005 Jan 01; 47(1):103-9. PubMed ID: 15603860
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.